These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15719220)

  • 1. Subtle effects of ketamine on memory when administered following stimulus presentation.
    LaPorte DJ; Blaxton TA; Michaelidis T; Robertson DU; Weiler MA; Tamminga CA; Lahti AC
    Psychopharmacology (Berl); 2005 Jul; 180(3):385-90. PubMed ID: 15719220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
    Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
    Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.
    Newcomer JW; Farber NB; Jevtovic-Todorovic V; Selke G; Melson AK; Hershey T; Craft S; Olney JW
    Neuropsychopharmacology; 1999 Feb; 20(2):106-18. PubMed ID: 9885791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.
    Taylor JH; Landeros-Weisenberger A; Coughlin C; Mulqueen J; Johnson JA; Gabriel D; Reed MO; Jakubovski E; Bloch MH
    Neuropsychopharmacology; 2018 Jan; 43(2):325-333. PubMed ID: 28849779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater vulnerability to the amnestic effects of ketamine in males.
    Morgan CJ; Perry EB; Cho HS; Krystal JH; D'Souza DC
    Psychopharmacology (Berl); 2006 Sep; 187(4):405-14. PubMed ID: 16896964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients.
    LaPorte DJ; Lahti AC; Koffel B; Tamminga CA
    J Psychiatr Res; 1996; 30(5):321-30. PubMed ID: 8923336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A
    Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.
    Hetem LA; Danion JM; Diemunsch P; Brandt C
    Psychopharmacology (Berl); 2000 Oct; 152(3):283-8. PubMed ID: 11105938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.
    Krystal JH; Petrakis IL; Limoncelli D; Webb E; Gueorgueva R; D'Souza DC; Boutros NN; Trevisan L; Charney DS
    Neuropsychopharmacology; 2003 Nov; 28(11):2020-8. PubMed ID: 12888778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cognitive impairments associated with NMDA receptor blockade in humans.
    Rowland LM; Astur RS; Jung RE; Bustillo JR; Lauriello J; Yeo RA
    Neuropsychopharmacology; 2005 Mar; 30(3):633-9. PubMed ID: 15647751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of unpleasant dreams after sub-anaesthetic ketamine.
    Blagrove M; Morgan CJ; Curran HV; Bromley L; Brandner B
    Psychopharmacology (Berl); 2009 Mar; 203(1):109-20. PubMed ID: 18949459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.
    Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC
    Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.